• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume8, Issue3

Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.

    Pratik Nandi Dippyoman Guha

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 45-54

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Covid 19 virus has shown its terror by causing severe acute respiratory disorder of human being’s effects shows a type of viral pneumonia. To address the anomaly the paper caries the motive encountering the viral infection with the help of interferon type 1 β. A basic discussion of effective INFβ1 and its introduction in the effective cells by Corona virus, plasma mediated delivery system along with development of asymptomatic conditions in non-affected individual. The plasma therapy considers plasma transfusion into effected individuals to boost their immunity against Corona virus. The plasma consists of antibodies, antigens as well as interferon to mediate with the viral infection and providing high effective rate. Satisfying these 2 goals was the basic motto of the paper along with a generation of asymptomatic condition in effected individuals. IBV (infectious bronchitis virus) is a type of influenza virus which has structural, genomic as well as symptomatic similarities with corona virus. Vaccination of non-effected individuals with IBV vac may allow to address the symptomatic similarities of Corona virus such as fever and breathing troubles. The generation of active immunity may render the extent of symptoms allowing persons to remain asymptomatic against the Corona infection. The study of structural phylogenomic of IBV along with Corona virus, and a contrast of similarities to support the asymptomatic postulates of the infected individuals has been explained.
Keywords:
  • PDF (570 K)
  • XML
(2021). Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.. European Journal of Molecular & Clinical Medicine, 8(3), 45-54.
Pratik Nandi Dippyoman Guha. "Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 45-54.
(2021). 'Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.', European Journal of Molecular & Clinical Medicine, 8(3), pp. 45-54.
Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 45-54.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 718
  • PDF Download: 517
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus